It is easy to understand that PPARG polymorphisms in the promoter region, as well as missense polymorphisms in the exonic region, may cause metabolic disorders such as hypercholesterolemia, hypertriglyceridemia, and hyperglycemia, which subsequently increase the risk of CAD. The gene discussed is PPARG; the disease is hypertriglyceridemia.